NCT05276310 2026-04-21A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard TherapyImmuneOncia Therapeutics Inc.Phase 1 Recruiting62 enrolled
NCT03459222 2026-04-06An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have SpreadBristol-Myers SquibbPhase 1/2 Completed229 enrolled 21 charts